Published in Pharmacogenomics J on January 01, 2004
Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J (2008) 2.31
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs. Curr Neuropharmacol (2015) 1.11
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand (2012) 0.87
Permeation, regulation and control of expression of TRP channels by trace metal ions. Pflugers Arch (2014) 0.85
Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila. Psychopharmacology (Berl) (2016) 0.79
Disrupted in schizophrenia 1 modulates medial prefrontal cortex pyramidal neuron activity through cAMP regulation of transient receptor potential C and small-conductance K+ channels. Biol Psychiatry (2014) 0.78
Decreased levels of canonical transient receptor potential channel 3 protein in the rat cerebral cortex after chronic treatment with lithium or valproate. Res Pharm Sci (2016) 0.75
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses (1995) 2.53
Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry (1997) 2.08
Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. Proc Natl Acad Sci U S A (1996) 1.53
Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur J Clin Pharmacol (1983) 1.38
The Evolutionary History of DROSOPHILA BUZZATII. III. Cytogenetic Relationships between Two Sibling Species of the Buzzatii Cluster. Genetics (1982) 1.36
Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4. Nature (1994) 1.35
Evolution of the mojavensis cluster of cactophilic Drosophila with descriptions of two new species. J Hered (1990) 1.34
Experimental denervation of ocular muscles. A critique of the concept of "ocular myopathy". Arch Neurol (1969) 1.32
Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J Protozool (1983) 1.29
Health information Websites: characteristics of US users by race and ethnicity. J Telemed Telecare (2007) 1.26
Audio and visual stimulation reduces patient discomfort during screening flexible sigmoidoscopy. Am J Gastroenterol (1998) 1.17
Prostate adenocarcinoma presenting as a large supraclavicular mass. Rev Urol (2001) 1.16
Recombination-induced chromosomal heterosis. Genetics (1968) 1.14
Income, language, and citizenship status: factors affecting the health care access and utilization of Chinese Americans. Health Soc Work (1998) 1.09
The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis. Tubercle (1986) 1.08
Effects of Ca++ depletion on the asexual cell cycle of Plasmodium falciparum. Am J Trop Med Hyg (1982) 1.06
Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligation. J Allergy Clin Immunol (1997) 1.05
Evolutionary cytogenetics of the Drosophila buzzatii species complex. Heredity (Edinb) (1993) 1.03
Rapid effects of veratridine, tetrodotoxin, gramicidin D, valinomycin and NaCN on the Na+, K+ and ATP contents of synaptosomes. J Neurochem (1977) 1.02
Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis (2001) 0.98
Temporal relationships on macromolecular synthesis during the asexual cell cycle of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1985) 0.98
Essential role of the Vp2 and Vp3 DNA-binding domain in simian virus 40 morphogenesis. J Virol (1995) 0.96
Phylogenetic analysis of the repleta species group of the genus Drosophila using multiple sources of characters. Mol Phylogenet Evol (2000) 0.95
The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry (1997) 0.93
Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry (1994) 0.93
Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain (1978) 0.92
Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Res (1999) 0.91
Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J Affect Disord (1999) 0.91
High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry (1997) 0.91
Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem (1993) 0.90
Fitness of karyotypes in Drosophila pseudoobscura. Genetics (1975) 0.89
Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP. Int J Impot Res (2002) 0.89
Factors influencing fitness in chromosomal strains in Drosophila subobscura. Genetics (1972) 0.88
Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist. J Clin Invest (1988) 0.88
Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man. J Clin Endocrinol Metab (1976) 0.88
Degradation and localization of IgG injected into Friend erythroleukemic cells by fusion with erythrocyte ghosts. FEBS Lett (1977) 0.87
Acute renal failure secondary to myoglobinuria associated with Legionnaires' disease. Chest (1983) 0.87
The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem (1996) 0.86
Effect of calpain inhibitors on the invasion of human erythrocytes by the parasite Plasmodium falciparum. Biochim Biophys Acta (1991) 0.84
Plasmodium falciparum: underestimation of dihydrofolate reductase and dihydropteroate synthase polymorphism in field samples: a technical shortcoming of nested PCR assays with mutation-specific primers. Exp Parasitol (2001) 0.84
Production of DNA-recombinant polypeptides by tac-inducible vectors using micromolar concentrations of IPTG. Biotechniques (1993) 0.84
Serotonin receptors in hippocampus and frontal cortex. Eur J Pharmacol (1980) 0.83
Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition. J Pharmacol Exp Ther (1976) 0.83
In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activity. Neurochem Res (1988) 0.83
Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry (2001) 0.83
Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin. J Clin Invest (1984) 0.83
Effect of verapamil on pulmonary and eicosanoid responses to endotoxin in awake sheep. J Appl Physiol (1985) (1988) 0.83
Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats. Synapse (1999) 0.82
Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. Eur J Surg Oncol (2007) 0.82
A quantitative study of ultramicroinjection of macromolecules into animal cells. Cell (1976) 0.82
Storage of organochlorine pesticides in the body fat of people in Western Australia. IMS Ind Med Surg (1968) 0.82
Programmed cell death in the tobacco hornworm, Manduca sexta: alteration in protein synthesis. Microsc Res Tech (1996) 0.82
1-Isopropylamino-3-(4-indanoxy)-2-propanol HC1: a potent beta-adrenoreceptor antagonist. Br J Pharmacol (1970) 0.82
Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry (1994) 0.82
Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem (1997) 0.82
Cytochemical localisation of calcium ATPase activity during the erythrocytic cell cycle of Plasmodium falciparum. Int J Parasitol (2001) 0.82
Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry (1997) 0.81
Isolation and identification of actin-binding proteins in Plasmodium falciparum by affinity chromatography. Mem Inst Oswaldo Cruz (2000) 0.81
Role of Ca2+ in preserving viability of Friend erythroleukaemic cells after ultramicroinjection. J Cell Sci (1977) 0.81
Altered TRPC7 gene expression in bipolar-I disorder. Biol Psychiatry (2001) 0.81
Effect of low temperature on the in vitro growth of Plasmodium falciparum. J Eukaryot Microbiol (1993) 0.81
Rejuvenation of degenerative thymus by oral melatonin administration and the antagonistic action of melatonin against hydroxyl radical-induced apoptosis of cultured thymocytes in mice. J Pineal Res (2001) 0.80
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse (1993) 0.80
Controlled exercise elevates plasma but not urinary MHPG and VMA. Psychiatry Res (1981) 0.80
Sexual dysfunction in women with HIV. Sex Transm Infect (2005) 0.80
A simple technique for entrapping rifampicin and isoniazid into liposomes. Tubercle (1986) 0.80
Plasmodium falciparum: increased and multiple invasion during short periods of time. J Protozool (1990) 0.80
Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. Brain Res (1991) 0.80
Determination of picogram levels of brain serotonin by a simplified liquid chromatographic electrochemical detection assay. Brain Res Bull (1979) 0.80
Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem (1999) 0.80
The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Clin Pharmacol Ther (1984) 0.80
Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.79
Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding. J Neurochem (1993) 0.79
Formation and clearance of norepinephrine glycol metabolites in mouse brain. J Neurochem (1984) 0.79
Protein synthesis, DNA degradation, and morphological changes during programmed cell death in labial glands of Manduca sexta. Dev Genet (1997) 0.79
HIV testing after implementation of name-based reporting. JAMA (1999) 0.79
Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease. Neurosci Lett (1988) 0.79
Distribution of liposomes in tuberculous mice. Tubercle (1990) 0.79
The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. J Neurochem (2000) 0.79
Effect of oral clonidine, insulin-induced hypoglycemia and exercise on plasma GHRH levels in short-stature children. Acta Endocrinol (Copenh) (1990) 0.79
Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography. J Neurochem (1981) 0.78
G-protein involvement in central-nervous-system muscarinic-receptor-coupled polyphosphoinositide hydrolysis. Biochem J (1988) 0.78
[3H]inositol 1,4,5-triphosphate binding in human cerebral cortex. Neurosci Lett (1988) 0.78